Web25 ago 2024 · Our phase II feasibility study (JCOG0206) (8, 9) conducted just before JCOG0602 trial demonstrated that we can accurately diagnose the target disease (i.e. any of ovarian, tubal and peritoneal cancers) and stage (either of stage III or IV disease) without diagnostic laparotomy or laparoscopy or only by clinical findings such as diagnostic … Web1 set 2016 · We, the Japan Clinical Oncology Group (JCOG), conducted a feasibility study of NACT (JCOG0206) [12], [13], and based on results of this phase II trial, we started a …
Segmentectomy Versus Lobectomy in Small-Sized Peripheral Non …
Web1 mag 2024 · The Japan Clinical Oncology Group (JCOG) phase III randomised clinical trial (JCOG0602) previously clearly demonstrated the reduced invasiveness of NACT compared with PDS, in terms of the number of surgeries, operation time, blood/ascites loss and transfusions, perioperative morbidity and extent of surgery [13]. http://www.jcog.jp/document/0602.pdf the ronan point collapse
Clinical significance of primary debulking surgery and neoadjuvant ...
Web13 ago 2024 · Click here to see when the next livestream is! This Brompton Grand Rounds was livestreamed on August 13, 2024. Joel Dunning from South Tees Hospital, … http://www.jcog.jp/en/trials/index.html Web25 ago 2024 · The JCOG0602 trial was designed as a randomized phase III non-inferiority study. The planned accrual period of 3 years was extended to 5 years because of slow … the ronan mill